Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $992790.7.

  • Addex Therapeutics' Treasury Shares fell 318.05% to $992790.7 in Q4 2024 from the same period last year, while for Dec 2024 it was $992790.7, marking a year-over-year decrease of 318.05%. This contributed to the annual value of $988598.5 for FY2024, which is 238.48% down from last year.
  • Latest data reveals that Addex Therapeutics reported Treasury Shares of $992790.7 as of Q4 2024, which was down 318.05% from $1.0 million recorded in Q4 2023.
  • In the past 5 years, Addex Therapeutics' Treasury Shares ranged from a high of $6.5 million in Q4 2022 and a low of $992790.7 during Q4 2024
  • Over the past 3 years, Addex Therapeutics' median Treasury Shares value was $1.0 million (recorded in 2023), while the average stood at $2.8 million.
  • Per our database at Business Quant, Addex Therapeutics' Treasury Shares tumbled by 8426.69% in 2023 and then tumbled by 318.05% in 2024.
  • Quarter analysis of 3 years shows Addex Therapeutics' Treasury Shares stood at $6.5 million in 2022, then plummeted by 84.27% to $1.0 million in 2023, then fell by 3.18% to $992790.7 in 2024.
  • Its Treasury Shares was $992790.7 in Q4 2024, compared to $1.0 million in Q4 2023 and $6.5 million in Q4 2022.